ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,616, issued on May 19, was assigned to CSL Innovation Pty Ltd (Melbourne, Australia).

"Complement C2 binding proteins and uses thereof" was invented by Matthew Hardy (Doreen, Australia), Con Panousis (Bundoora, Australia) and Rodrigo Morales (Port Melbourne, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to proteins comprising antigen binding sites that bind to human complement C2 (C2). The present disclosure also relates to methods of inhibiting complement activity in a subject as well as methods of treating or preventing complement-mediated disorders."

The patent was filed on Aug. 12, 2020, under Applicatio...